One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-130069
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 2 |
Affiliation: University of Michigan–Ann Arbor, University of Insubria, Maastricht University Medical Centre, University of Florence, Institut de Cancérologie de Bourgogne, The University of Texas Health Science Center at San Antonio, Vrije Universiteit Amsterdam, Amsterdam University Medical Centers, Hôpital Saint-Louis, Cornell University, The University of Texas MD Anderson Cancer Center, Guy's and St Thomas' NHS Foundation Trust, Radboud University Nijmegen, Radboud University Nijmegen Medical CentreFedratinib Induces Spleen Responses in Patients with Myeloproliferative Neoplasm-Associated Intermediate- or High-Risk Myelofibrosis (MF) Previously Exposed to Ruxolitinib (RUX), Regardless of Reason for Discontinuing RUX
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
